Extraparenchymal neurocysticercosis in the United States: a case report by Kelesidis, Theodoros & Tsiodras, Sotirios
CASE REPORT Open Access
Extraparenchymal neurocysticercosis in the
United States: a case report
Theodoros Kelesidis
1* and Sotirios Tsiodras
2
Abstract
Introduction: Neurocysticercosis is endemic in the developing world, but is becoming more common in the
United States due to immigration.
Case presentation: A 26-year-old Caucasian man presented with headache, nausea and vomiting and was found
to have hydrocephalus and meningitis. Brain imaging and immunological studies were suggestive of
neurocysticercosis. Endoscopic removal of the cyst resulted in resolution of symptoms. This case represents a
combination of two rare presentations of extraparenchymal neurocysticercosis; intraventricular neurocysticercosis
and subarachnoid neurocysticercosis.
Conclusion: Although neurocysticercosis is pleomorphic in its presentation, extraparenchymal neurocysticercosis
may be challenging to diagnose and treat. Clinicians should be aware of this condition given increasing incidence
in the United States.
Introduction
Neurocysticercosis (NCC) is the most common disease
causing cystic lesions in the central nervous system, espe-
cially in developing and tropical countries [1]. However,
extraparenchymal NCC may be challenging to diagnose
and treat. Increasing immigration from endemic areas
will lead to an increasing frequency of extraparenchymal
NCC in the United States. Clinicians and neuroradiolo-
gists in the United States are often unaware of the radio-
graphic patterns of extraparenchymal NCC and the
potentially poor prognosis if not correctly diagnosed and
m a n a g e d .H e r e ,w ed e s c r i b eac a s eo fe x t r a p a r e n c h y m a l
NCC as a cause of chronic meningitis and hydrochepha-
lus in a patient and we discuss challenges in the diagnosis
and management of these cases.
Case presentation
A 26-year-old Caucasian man with history of diabetes mel-
litus presented to our emergency department complaining
of diffuse headache that had developed two months prior
to presentation. He also reported nausea and vomiting
that became progressively worse. He denied fever, chills,
photophobia or any other symptoms. He was born in
Mexico and moved to California when he was 18 years
old. A physical examination revealed a temperature of
37°C and mild neck stiffness but an examination including
funduscopy and ophthalmologic examination was other-
wise normal. Initial laboratory findings indicated a white
blood cell count of 6500/mm
3 with 75% polymorphonuc-
lear leukocytes, 15% lymphocytes and 8% monocytes.
His serum glucose was 90 mg/dL. The remainder of
the laboratory data was normal. An initial computed
tomography (CT) scan of his head showed hydrocephalus
(Figure 1). A lumbar puncture was performed and cere-
brospinal fluid (CSF) analysis revealed an opening pressure
of 400 mmHg, with 330 white blood cells/mm
3 with
14% neutrophils, 45% lymphocytes, 38% monocytes, 3%
eosinophils, 3 red blood cells/mm
3, a protein level of
84 mg/100 mL and a glucose level of 43 mg/100 mL. A
Gram stain and India ink stain of CSF were negative and
final bacterial, viral, fungal and mycobacterial cultures
were negative. Our patient was initially started on antimy-
cobacterial therapy for empiric treatment of possible
tuberculous meningitis. Magnetic resonance imaging
(MRI) of his brain revealed an absence of meningeal
enhancement, dilated lateral and third ventricles, with
aqueduct stenosis and a possible small cystic area in or
adjacent to the inferior aqueduct (Figures 2, 3, 4).
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positive for immunoglobulin G (IgG) cysticercosis anti-
body, with 1.31 optical density units (OD) (positive result
> 0.50 OD). His serum IgG cysticercosis antibody was
positive with 4.42 OD. The serological diagnosis was con-
firmed by enzyme-linked immunoelectrotransfer blot
assay performed for both serum and CSF. On further his-
tory, our patient mentioned that he used to eat under-
cooked meat when he was in Mexico. A diagnosis of
extraparenchymal NCC was made. Our patient underwent
endoscopic removal of the cyst and three weeks of therapy
with albendazole (15 mg/kg/day) and corticosteroids was
initiated. Postoperatively, our patient had a full range of
extraocular movements, no periaqueductal injury and
complete resolution of his presenting symptoms. Pathol-
ogy findings confirmed the diagnosis of NCC (Figure 5).
Discussion
NCC is the most common parasitic infestation of the
central nervous system worldwide but is also of emer-
ging importance in the United States, especially in areas
with high volumes of immigration from endemic regions
of Latin America [2]. A recent study reported an overall
frequency of subarachnoid cysts in 2%, ventricular cysts
in 6%, and hydrocephalus in 16% of NCC cases [2].
Intraventricular NCC, the presence of Taenia solium
cysts in the cerebral ventricular system, occurs in 7-30%
of patients with NCC [3]. According to recent studies,
extraparenchymal NCC is probably more frequent than
previously thought [3]. We have recently reviewed the
pathogenesis, diagnosis, clinical manifestations and
treatment of extraparenchymal NCC in the United
States [4].
Figure 1 CT of his head (transverse view) showing presence of
hydrocephalus and dilation of ventricles.
Figure 2 Midsagittal T1-weighted MRI of his head showing
hydrocephalus with stenosis of aqueduct (arrow).
Figure 3 Cine flow MRI: lack of cerebral aqueduct flow void
(arrow) but no obvious cyst.
Figure 4 Midsagittal T2-weighted MRI of his head showing
hydrocephalus with lack of cerebral aqueduct patency (arrow).
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Page 2 of 4In our case extraparenchymal NCC occurred in an
adult male Hispanic immigrant who presented with sub-
acute intracranial hypertension from hydrocephalus and
chronic meningitis, characterized by a mild-to-moderate
CSF lymphocytic pleocytosis, mild-to-moderate increase
in protein, and minimal meningeal signs on exam. Intra-
cranial hypertension is a common manifestation of
extraparenchymal NCC and in our case was caused by
the direct obstruction of the aqueduct by a cyst and
possible blockage of CSF pathways within the subarach-
noid space. This blockage may have been due to the
inflammatory reaction at the tentorium opening.
Extraparenchymal NCC is associated with a local
inflammatory response with high protein concentration
and cell counts in the CSF [5]. Clinical manifestations
and CSF findings are similar to the more common
tuberculous and fungal meningitis [5,6], since the CSF
findings consist of pleocytosis (usually lymphocytic but
frequently polymorphonuclear), reduced glucose and
elevated protein [5]. In one series of cysticercal menin-
goencephalitis, confusion with tubercular meningitis
was present in 61.5% cases [5]. An important differen-
tiating feature is the presence of eosinophils (above
5%) in the CSF, which is usually seen only in the initial
phases of the illness but occurs in only 15% of patients
[3]. The presence of chronic meningitis, hydrocepha-
lus, and absence of eosinophils in the CSF of a patient
coming from an endemic area for tuberculosis sug-
gested the diagnosis of tuberculous meningitis, and our
patient was started on empiric treatment for tuberculo-
sis until a diagnosis of neurocysticercosis was made. It
is often common practice to attribute chronic meningi-
tis and hydrocephalus to tubercular meningitis in the
presence of appropriate epidemiologic history and treat
empirically by shunting and antitubercular therapy.
Thus, an astute clinical acumen is required to make
the diagnosis of cysticercal meningitis.
Neuroimaging findings of extraparenchymal cysticerci
are subtle and are usually not seen by CT. The most com-
mon CT finding in subarachnoid NCC is hydrocephalus
[7]. In our case, there was hydrocephalus and non-specific
cerebral aqueduct stenosis but no obvious imaging evi-
dence of a parasite in the parenchymal or extraparenchy-
mal space. The cyst was located in the aqueduct but was
very subtle and was initially missed by the radiologist.
Because the cyst membrane is thin and the fluid is iso-
dense with the cerebrospinal fluid, uninflamed extrapar-
enchymal cysticerci are usually not visible on CT scanning
and may only reveal subtle, indirect findings on MRI [7].
MRI has good sensitivity for detecting intraventricular
cysticercosis and although it did not initially clear the
diagnostic dilemma in this case, contrast MRI was helpful
in clarifying the morphology of the lesion. However, only
the presence of cystic lesions, demonstrating the scolex
of the larval stage of T. solium, can be considered pathog-
nomonic of NCC and an absolute criterion for a defini-
tive diagnosis of the disease [1,8,9]. Thus, previous
studies have shown that optimal MRI protocols should
include axial fluid-attenuated inversion recovery imaging
to obtain maximal rates of scolex detection [8]. In our
case the exact etiology of the cystic lesion was confirmed
on pathological examination of the specimen.
The diagnosis in our case was made based on the pre-
sence of a lesion highly suggestive of NCC on neuroi-
maging study, positive serum immunoassay for the
detection of anticysticercal antibodies, positive CSF
immunoassay for detection of anticysticercal antibodies
and epidemiologic criteria including an individual com-
ing from an area where cysticercosis is endemic [1].
However, extensive and comprehensive revision of the
diagnostic criteria of NCC, especially of extraparenchy-
mal NCC, is mandatory according to many recent publi-
cations [5,7,10].
There is still no consensus regarding optimal treatment
strategies in patients with intraventricular NCC [3,6,10].
Various therapeutic modalities include antihelminthic
medication, microneurosurgical removal, ventriculoperi-
toneal shunting, and endoscopic management [5]. Medi-
cal therapy alone is not favored because of the limited
efficacy in such cases, and a risk of developing acute
hydrocephalus during the clinical treatment period
because of the mobile nature of the intraventricular cyst
[3,11]. Thus, surgical evaluation is necessary prior to
medical treatment [5] and in patients presenting with
acute hydrocephalus, surgery is the only option [3,11].
Endoscopic approaches for intraventricular NCC have
been described in recent years and often allow for cyst
removal and hydrocephalus treatment, freeing the patient
from shunt procedures [12].
Figure 5 Pathology specimen. Wavy, somewhat refractile cuticle
with presence of loose, reticular tissue.
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Page 3 of 4Although subarachnoid cysts were not identified, our
patient’s clinical presentation and CSF analysis was con-
sistent with cysticercal meningitis and subarachnoid
cysticercosis. Thus, our case represents a combination of
two rare presentations of extraparenchymal NCC; intra-
ventricular NCC and subarachnoid NCC. There was a
consensus among treating neurologists, neurosurgeons
and infectious disease consultants to use albendazole at a
dose of 15 mg/kg/day for a minimum of 21 days as the
antiparasitic treatment. Our patient also received steroids
for three weeks and the doses and duration used were
equal or bigger than the known standard doses to treat
parenchymal disease [6]. However, with controversy in
the literature over the optimal management of this condi-
tion and without further evidence-based guidelines to
help management of extraparenchymal NCC, the deci-
sion about the total dose and duration of antiparasitic
and steroid therapy was at the discretion of the treating
neurologist.
Conclusion
In summary, the case presented here is an important
reminder that intraventricular NCC should be considered
in the differential diagnosis of obstructive hydrocephalus
with the radiographic appearance of a cystic lesion in the
third, aqueduct, or fourth ventricle. Extraparenchymal
NCC may be a more common form of NCC in the United
States than previously thought. Because clinicians in the
US outside the southwest US are often unfamiliar with
NCC as a cause of chronic meningitis, chronic ventriculi-
tis, or hydrocephalus without obvious cysts, the diagnosis
of extraparenchymal NCC often depends on the correct
interpretation of neuroimaging which may miss the diag-
nosis. Thus, meningeal and intraventricular NCC should
always be considered by clinicians and radiologists in the
differential diagnosis of chronic meningitis and hydroce-
phalus, particularly in patients from Latin America.
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